Jefferies Initiates Coverage On Haemonetics with Buy Rating, Announces Price Target of $150
Benzinga Newsdesk 1 week ago
Analyst RatingsNewsInitiationPrice Target
This page contains a summary, not the full article. Continue to benzinga.com to read the original report.
Jefferies analyst Young Li initiates coverage on Haemonetics (NYSE:HAE) with a Buy rating and announces Price Target of $150.
Jefferies analyst Young Li initiates coverage on Haemonetics (NYSE:HAE) with a Buy rating and announces Price Target of $150.
